TerminatedNot Applicable

Observational Study of Rapid Sequence Intubation Drug Delivery Using Intraosseous and Intravenous Access.

Stopped: For poor enrollment

United States4 participantsStarted 2012-02

Plain-language summary

This study will evaluate using intraosseous vascular access and intravenous vascular access to give patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties. The investigators think the device operator will find the intraosseous and intravenous routes equal for drug delivery.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Requires rapid sequence intubation * Succinylcholine is chosen paralytic agent * Intravenous (IV) or Intraosseous (IO) access has been established for rapid sequence intubation * For IV access patients, their rapid sequence intubation case is the next occurring IV rapid sequence intubation case following an enrolled IO Rapid Sequence Intubation (RSI) case. Exclusion Criteria: * Vascular access other than IV or IO has been established

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Time From First Drug Delivery to Operator-perceived Sufficient Relaxation to Perform Endotracheal Tube Placement

Timeframe: during rapid sequence intubation procedure, average expected time frame 30 minutes

Intubation Difficulty Scale

Timeframe: during rapid sequence intubation procedure, average expected time frame 30 minutes

Operator Satisfaction With Intubating Conditions Using Visual Analog Scale

Timeframe: during rapid sequence intubation procedure, average expected time frame 30 minutes

Failure Rate of Endotracheal Intubation and Requirement for Alternative Airway Management Methods

Timeframe: during rapid sequence intubation procedure, average time frame 30 minutes

Trial details

NCT IDNCT01486407

SponsorVidacare Corporation

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2012-12

Results submitted2025-12-12

View on ClinicalTrials.gov More Airway Control trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Time From First Drug Delivery to Operator-perceived Sufficient Relaxation to Perform Endotracheal Tube Placement

Timeframe: during rapid sequence intubation procedure, average expected time frame 30 minutes

Intubation Difficulty Scale

Timeframe: during rapid sequence intubation procedure, average expected time frame 30 minutes

Operator Satisfaction With Intubating Conditions Using Visual Analog Scale

Timeframe: during rapid sequence intubation procedure, average expected time frame 30 minutes

Failure Rate of Endotracheal Intubation and Requirement for Alternative Airway Management Methods

Timeframe: during rapid sequence intubation procedure, average time frame 30 minutes